Supply Chain Intelligence

Actinium Pharmaceuticals, Inc. Supply Chain

ATNM supply chain intelligence for Actinium Pharmaceuticals, Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.

ATNM ·Last updated 2026-07-30 · Interactive map →

Data compiled by Redley Lamar · ChainSifter Intelligence

3Suppliers
8Customers
3Debt Items
20Related Chains

Actinium Pharmaceuticals, Inc. Suppliers

TickerNameConfidenceEvidence
AC-225-AND-OTHER-RADIOISOTOPES-SUPPLIERS AC-225-AND-OTHER-RADIOISOTOPES-SUPPLIERS 92% We maintain supply agreements with multiple domestic and international suppliers of Ac-225 and other radioisotopes, providing priority access and redundancy to ensure reliable supply.
CONTRACT-MANUFACTURING-ORGANIZATIONS CONTRACT-MANUFACTURING-ORGANIZATIONS 92% We have qualified multiple contract manufacturers capable of producing our drug products under cGMP conditions.
RADIOPHARMACEUTICAL-LOGISTICS-PROVIDERS RADIOPHARMACEUTICAL-LOGISTICS-PROVIDERS 92% We have established relationships with specialized radiopharmaceutical logistics providers capable of cold-chain distribution, real-time tracking, and just-in-time delivery to clinical sites and comm…

Actinium Pharmaceuticals, Inc. Customers

TickerNameConfidenceEvidence
IMMEDICA-PHARMA-AB IMMEDICA-PHARMA-AB 92% Upon signing, the Company was entitled to an upfront, non-refundable payment of $ 35 million from Immedica, which was received in May 2022.
JONESTRADING-INSTITUTIONAL-SERVICES-LLC JONESTRADING-INSTITUTIONAL-SERVICES-LLC 90% In August 2020, the Company entered into the Capital on Demand™ Sales Agreement with JonesTrading Institutional Services LLC, “JonesTrading”, pursuant to which the Company may sell, from time to time…
GOVERNMENT-SPONSORED-ENTITY GOVERNMENT-SPONSORED-ENTITY 80% The Company has a grant from a government-sponsored entity for research and development related activities that provides for payments for reimbursed costs, which included overhead and general and adm…
KURA Kura Oncology, Inc. 72% eferred to and treated in comprehensive treatment centers for in-patient treatment as opposed to community, outpatient-based care. As a result, we believe the majority of AML and High-risk MDS patien…
KURA Kura Oncology, Inc. 72% Reciprocal relationship from KURA graph: Reciprocal relationship from ATNM graph: eferred to and treated in comprehensive treatment centers for in-patient treatment as opposed to community, outpatien…
MNPR Monopar Therapeutics Inc. 72% Reciprocal relationship from MNPR graph: ing on new radiopharmaceutical compounds and linkers. 11 Table of Contents Manufacturing ALXN1840 We do not currently own or operate manufacturing facilities …
SNDX Syndax Pharmaceuticals, Inc. 72% eferred to and treated in comprehensive treatment centers for in-patient treatment as opposed to community, outpatient-based care. As a result, we believe the majority of AML and High-risk MDS patien…
SNDX Syndax Pharmaceuticals, Inc. 72% Reciprocal relationship from SNDX graph: Reciprocal relationship from ATNM graph: eferred to and treated in comprehensive treatment centers for in-patient treatment as opposed to community, outpatien…

Actinium Pharmaceuticals, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
ATNM-DEBT-7949 Warrants outstanding: 0.003 90% xbrl warrant detail from xbrl 2022-12-31.
ATNM-DEBT-7950 Xbrl Convertible 90% xbrl convertible detail from xbrl 2012-12-31.
ATNM-DEBT Debt stack $1.7M 90% Market cache reports total debt of $1.7M.

Actinium Pharmaceuticals, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Actinium Pharmaceuticals, Inc..

Actinium Pharmaceuticals, Inc. Ownership

HolderNameConfidenceEvidence
ATNM-OWNER-VANGUARD-CAPITAL-MANAGEMENT-LLC VANGUARD CAPITAL MANAGEMENT LLC 90% 13F overlay lists VANGUARD CAPITAL MANAGEMENT LLC as top holder; 58 tracked holders.

Actinium Pharmaceuticals, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
KURA Kura Oncology, Inc. 100.00 1 ['customer']
NBTX Nanobiotix S.A. 100.00 2
RADX Radiopharm Theranostics Limited 100.00 2
TLX Telix Pharmaceuticals Limited 100.00 1 ['spend']
SNSE Sensei Biotherapeutics, Inc. 100.00 2
SNDX Syndax Pharmaceuticals, Inc. 100.00 1 ['customer']
CATX Perspective Therapeutics, Inc. 100.00 2
BSX Boston Scientific Corporation 100.00 2
CLRB Cellectar Biosciences, Inc. 100.00 2
AZN AstraZeneca PLC 100.00 2
BMYMP Bristol-Myers Squibb Co 100.00 2
DRTS Alpha Tau Medical Ltd. 100.00 1 ['spend']
LNTH Lantheus Holdings, Inc. 100.00 2
JANX Janux Therapeutics, Inc. 100.00 2
MIRATI MIRATI 50.00 2
HTGC Hercules Capital, Inc. 50.00 2
BHC Bausch Health Companies Inc. 50.00 2
ETON Eton Pharmaceuticals, Inc. 50.00 2
ALLR Allarity Therapeutics, Inc. 50.00 2
INCY Incyte Corporation 50.00 2
View ATNM supply chain intel →

Explore the full interactive supply chain map for Actinium Pharmaceuticals, Inc..

Open ATNM supply chain map →
ChainSifter · Guerilla Finance Terms Disclaimer ← Back to Map